A nurse is caring for a client whose current bag of total parenteral nutrition (TPN) has finished infusing, and the next bag is not yet available. Which of the following fluids should the nurse prepare to administer?

A) "Reading back the provider's prescription is only necessary for high alert medications": Reading back the provider's prescription is a crucial step in preventing medication errors and should be done for all medications, not just high alert ones. Verbal orders are prone to miscommunication, so repeating the order back to the provider helps ensure accuracy and clarity.

B) "Providers should cosign all verbal prescriptions": This is the correct intervention. Verbal prescriptions are considered high risk for medication errors due to misinterpretation or miscommunication. Having the provider cosign verbal prescriptions adds an extra layer of verification and accountability, reducing the likelihood of errors.

C) "Utilize assistive personnel as a witness to verbal provider prescriptions": While involving another healthcare professional as a witness to verbal prescriptions may provide additional verification, it is not a standard practice and may not be feasible in all situations. Relying solely on assistive personnel for this purpose may not ensure accuracy and could introduce potential communication errors.

D) "Safe abbreviations should only be used by providers": Safe abbreviations should be used by all healthcare team members, not just providers, to prevent medication errors. Standardizing abbreviations reduces the risk of misinterpretation and enhances communication among healthcare providers.

A) The client will wear his reading glasses when drawing up a dose of insulin glargine: This is the correct expected outcome. Older adults may experience visual changes that affect their ability to see clearly. Wearing reading glasses or using other visual aids can help ensure accurate measurement and administration of insulin glargine, reducing the risk of dosing errors.

B) The client will administer insulin glargine before each meal: This statement is incorrect. Insulin glargine is a long-acting insulin analog that is typically administered once daily at the same time each day, rather than before each meal. It provides a steady level of insulin over a 24-hour period and is not directly related to meal timing.

C) The client will use the deltoid muscle as an injection site: Using the deltoid muscle as an injection site for insulin glargine is not recommended. Insulin glargine is usually injected suIcutaneously into the abdomen, thigh, or upper arm. The deltoid muscle may not provide consistent absorption of insulin and is not commonly used for insulin injections.

D) The client will take an additional dose of insulin glargine prior to exercise: Taking an additional dose of insulin glargine prior to exercise is not a typical part of insulin glargine therapy. Adjustments to insulin doses for exercise should be made under the guidance of a healthcare provider, and additional doses of insulin glargine are not usually recommended for this purpose.